The Heterotrimeric G-protein GGraphic Is Localized to the Insulin Secretory Granules of Graphic-Cells and Is Involved in Insulin Exocytosis (*)

  1. Robert J. Konrad(1),
  2. Robert A. Young(1),
  3. Rae D. Record(1),
  4. Robert M. Smith(1),
  5. Paul Butkerait(2),
  6. David Manning(2),
  7. Leonard Jarett(1) and
  8. Bryan A. Wolf(1)(§)
  1. From the (1) Departments of Pathology and Laboratory Medicine and
  2. (2) Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
  1. § To whom correspondence should be addressed:
    University of Pennsylvania School of Medicine, Dept. of Pathology and Laboratory Medicine, 217 John Morgan, Philadelphia, PA 19104-6082.
    Tel.: 215-898-0025; Fax: 215-573-2266.

Abstract

Mastoparan, a tetradecapeptide found in wasp venom that stimulates G-proteins, increases insulin secretion from β-cells. In this study, we have examined the role of heterotrimeric G-proteins in mastoparan-induced insulin secretion from the insulin-secreting β-cell line β-TC3. Mastoparan stimulated insulin secretion in a dose-dependent manner from digitonin-permeabilized β-TC3 cells. Active mastoparan analogues mastoparan 7, mastoparan 8, and mastoparan X also stimulated secretion. Mastoparan 17, an inactive analogue of mastoparan, did not increase insulin secretion from permeabilized β-TC3 cells. Mastoparan-induced insulin secretion from permeabilized β-TC3 cells was inhibited by pretreatment of the cells with pertussis toxin, suggesting that mastoparan-induced insulin secretion is mediated through a pertussis toxin-sensitive G-protein present distally in exocytosis. Enriched insulin secretory granules (ISG) were prepared by sucrose/nycodenz ultracentrifugation. Western immunoblotting performed on β-TC3 homogenate and ISG demonstrated that Gαi was dramatically enriched in ISG. Levels of Gαo and Gαq were comparable in homogenate and ISG. Mastoparan stimulated ISG GTPase activity in a pertussis toxin-sensitive manner. Mastoparan 7 and mastoparan 8 also stimulated GTPase activity in the ISG, while the inactive analogue mastoparan 17 had no effect. Selective localization of Gαi to ISG was confirmed with electron microscopic immunocytochemistry in β-TC3 cells and β-cells from rat pancreas. In contrast to Gαo and Gαq, Gαi was clearly localized to the ISG. Together, these data suggest that mastoparan may act through the heterotrimeric G-protein Gαi located in the ISG of β-cells to stimulate insulin secretion.

Footnotes

  • * This work was supported by a Juvenile Diabetes Foundation Fellowship (to R. J. K.), National Institutes of Health Research Grants RDK43354 (to B. A. W.), R01 GM34781 (to D. M.), R01 DK28143 (to L. J.), a National Institutes of Health Research Career Development Award K04 DK02217 (to B. A. W.), the William Pepper Fund of the University of Pennsylvania (to B. A. W.), and the Diabetes Endocrine Research Center (DK19525). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    ISG

    insulin secretory granule

    TES

    2-([2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino)ethanesulfonic acid

    PBS

    phosphate-buffered saline

    MES

    2-(N-morpholino)ethanesulfonic acid

    GTPGraphicS

    guanosine 5′-O-(thiotriphosphate).

« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement